Cargando…

Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals

Drug safety is an important issue, especially in the experimental phases of development. Adverse immunostimulation (AI) is sometimes encountered following treatment with biopharmaceuticals, which can be life‐threatening if it results in a severe systemic inflammatory reaction. Biopharmaceuticals tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reijers, Joannes A. A., Malone, Karen E., Bajramovic, Jeffrey J., Verbeek, Richard, Burggraaf, Jacobus, Moerland, Matthijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595286/ https://www.ncbi.nlm.nih.gov/pubmed/30920013 http://dx.doi.org/10.1111/bcp.13938

Ejemplares similares

Potential Influence of Endothelial Adsorption on the Delayed Time to Maximum Concentration of Biopharmaceuticals
por: Reijers, Joannes A. A., et al.
Publicado: (2017)

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216
por: Reijers, Joannes A. A., et al.
Publicado: (2017)

Remarkable Pharmacokinetics of Monoclonal Antibodies: A Quest for an Explanation
por: Reijers, Joannes A. A., et al.
Publicado: (2016)

Clinical Evaluation of Humira(®) Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
por: Dillingh, Marlous R., et al.
Publicado: (2016)

Trastuzumab Induces an Immediate, Transient Volume Increase in Humans: A Randomised Placebo-Controlled Trial
por: Reijers, Joannes A.A., et al.
Publicado: (2015)

Whole blood assay as a model for in vitro evaluation of inflammasome activation and subsequent caspase-mediated interleukin-1 beta release
por: Tran, Thi Anh Thu, et al.
Publicado: (2019)

Novel SGLT2 inhibitor: first‐in‐man studies of antisense compound is associated with unexpected renal effects
por: van Meer, Leonie, et al.
Publicado: (2017)

Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies
por: Reijers, Joannes A. A., et al.
Publicado: (2016)

On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events
por: Späth, Peter J., et al.
Publicado: (2015)

The dark side
por: Petsko, Gregory A
Publicado: (2000)

Dark zone of the Greenland Ice Sheet controlled by distributed biologically-active impurities
por: Ryan, Jonathan C., et al.
Publicado: (2018)

Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007)

Editorial: Vaccines and Immunostimulants for Finfish
por: Munang'andu, Hetron M., et al.
Publicado: (2020)

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease
por: Kallend, D.G., et al.
Publicado: (2016)

The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial
por: Grievink, Hendrika W., et al.
Publicado: (2020)

Chemical Impurities: An Epistemological Riddle with Serious Side Effects
por: Abdin, Ahmad Yaman, et al.
Publicado: (2020)

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
por: Batista-Duharte, Alexander, et al.
Publicado: (2023)

Immunostimulant Effect of Egyptian Propolis in Rabbits
por: Nassar, Somya A., et al.
Publicado: (2012)

Cyberbiosecurity for Biopharmaceutical Products
por: Mantle, Jennifer L., et al.
Publicado: (2019)

The Dark Side of the Universe
por: De Rújula, A.
Publicado: (2021)

The dark side of browning
por: Tamucci, Kirstin A., et al.
Publicado: (2017)

A randomized controlled trial with a delayed‐type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man
por: Saghari, Mahdi, et al.
Publicado: (2020)

Biopharmaceuticals : biochemistry and biotechnology
por: Walsh, Gary
Publicado: (2003)

Biopharmaceuticals : biochemistry and biotechnology /
por: Walsh, Gary
Publicado: (1998)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
por: Rodríguez, Sandra, et al.
Publicado: (2020)

Humoral immunostimulation. IV. Role of complement
Publicado: (1975)

Phytol-Derived Novel Isoprenoid Immunostimulants
por: Chowdhury, Roshni Roy, et al.
Publicado: (2012)

Immunostimulating Effects of Extract of Acanthopanax sessiliflorus
por: Kim, Jung-Hoon, et al.
Publicado: (2013)

Effects of interleukin-2 in immunostimulation and immunosuppression
por: Pol, Jonathan G., et al.
Publicado: (2019)

Immunostimulants in respiratory diseases: focus on Pidotimod
por: Puggioni, Francesca, et al.
Publicado: (2019)

The Dark Side of Antibiotics: Adverse Effects on the Infant Immune Defense Against Infection
por: Shekhar, Sudhanshu, et al.
Publicado: (2020)

Assessing the Immunogenicity of Biopharmaceuticals
por: Pineda, Carlos, et al.
Publicado: (2016)

The dark side of the Moon
Publicado: (1998)

Dark Side of the Universe
Publicado: (2016)

In the dark on the sunny side
por: Baggett, Larry
Publicado: (2014)

The dark side of technology
por: Townsend, Peter
Publicado: (2016)

The dark side of the proton
por: McCullough, Matthew, et al.
Publicado: (2022)

The Dark Side of the Universe
por: Licia Verde
Publicado: (2008)

The dark side of the esophagus
por: Martins, Daniela, et al.
Publicado: (2021)

The dark side of immunotherapy
por: Okwundu, Nwanneka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bn15fbo0dlng955s68n2ok20jt